Drug Profile
Research programme: Staphylococcus aureus vaccine conjugate trivalent - Nabi Biopharmaceuticals
Alternative Names: StaphVAX-Trivalent; Trivalent S. aureus vaccine (5, 8, 336) - Nabi BiopharmaceuticalsLatest Information Update: 31 May 2012
Price :
$50
*
At a glance
- Originator Nabi Biopharmaceuticals
- Class Bacterial vaccines; Conjugate vaccines; Polysaccharides; Toxoids
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Staphylococcal infections
Most Recent Events
- 31 Dec 2008 Discontinued - Preclinical for Staphylococcal infections (prevention) in USA (Parenteral)
- 25 Feb 2008 Suspended - Preclinical for Staphylococcal infections in USA (unspecified route)